Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-07-18 00:00:00 ET · period of report 2025-06-18 · accession 0001140361-25-026410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-07-18 | 2025-06-18 | RCKT | GRANADILLO PEDRO P | Dir | A - Grant | $0.00 | +54.7K | 54.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-18 | A | A | 30,000 | $0.00 | 30,000 | D | — | — | (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026. |
| 2 | Common | Common Stock | 2025-06-18 | A | A | 24,734 | $0.00 | 54,734 | D | — | — | (F2) Represents RSUs issued to the Reporting Person in lieu of director retainer fees of $70,000. The RSUs will vest in full on June 18, 2026. (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026. |